Expression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia

B7-H3 isoforms, 4IgB7-H3 (4Ig) and 2IgB7-H3 (2Ig) expression characteristics in acute myeloid leukemia (AML) remain unknown. This study investigated mRNA and membrane protein expression of two isoforms in AML cell lines and de novo patients by using RT-PCR and flow cytometry, and analyzed the B7-H3...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wei Zhang, Lingyi Zhang, Jun Qian, Jiang Lin, Qiaoyun Chen, Qian Yuan, Jingdong Zhou, Tingjuan Zhang, Jinning Shi, Hong Zhou
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
Acceso en línea:https://doaj.org/article/d8c8d09eae8f4426a9cd63794b646a46
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d8c8d09eae8f4426a9cd63794b646a46
record_format dspace
spelling oai:doaj.org-article:d8c8d09eae8f4426a9cd63794b646a462021-11-26T11:19:49ZExpression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia2165-59792165-598710.1080/21655979.2021.2001182https://doaj.org/article/d8c8d09eae8f4426a9cd63794b646a462021-11-01T00:00:00Zhttp://dx.doi.org/10.1080/21655979.2021.2001182https://doaj.org/toc/2165-5979https://doaj.org/toc/2165-5987B7-H3 isoforms, 4IgB7-H3 (4Ig) and 2IgB7-H3 (2Ig) expression characteristics in acute myeloid leukemia (AML) remain unknown. This study investigated mRNA and membrane protein expression of two isoforms in AML cell lines and de novo patients by using RT-PCR and flow cytometry, and analyzed the B7-H3 promoter methylation state by utilizing RQ-MSP. 4Ig was the dominant B7-H3 isoform. 2Ig mRNA expression rate and abundance were elevated in AML in comparison with controls (P=0.000 and 0.000), while no significant difference in 4Ig (P=0.802, P=0.398). Membrane protein levels of B7-H3 isoforms in AML was higher than controls, detected by total B7-H3 expression rate (P=0.002), total B7-H3 mean fluorescence intensity (MFI) ratio of blast cells and lymphocytes (MFI ratio) (P=0.000), and 4Ig B7-H3 MFI ratio (P=0.005). Compared with 2Iglow group, 2Ighigh patients had older age, lower NPM1 mutation, higher FLT3-ITD mutation, and declining complete remission (CR) rates (P=0.026, 0.012, 0.047, and 0.028). In B7-H3high group, there was a trend towards older age, –M4 and M5, worse karyotype, and lower CR rates, although with no marked difference (P>0.05). The overall survival (OS) of 2Ighigh and B7-H3high groups were shorter than that of 2Iglow and B7-H3low groups in the whole and non-M3 AML cohorts (P=0.006 and 0.046; P=0.003 and 0.032). Besides, an unmethylated B7-H3 promoter was identified. In conclusion, 2Ig mRNA and total B7-H3 isoforms membrane protein tended to have potential diagnostic value for AML. Specifically, high 2Ig mRNA expression and total B7-H3 membrane protein expression indicate worse OS. 4Ig and 2Ig expression are methylation-independent.Wei ZhangLingyi ZhangJun QianJiang LinQiaoyun ChenQian YuanJingdong ZhouTingjuan ZhangJinning ShiHong ZhouTaylor & Francis Grouparticle4ig b7-h32ig b7-h3acute myeloid leukemiaprognosisBiotechnologyTP248.13-248.65ENBioengineered, Vol 0, Iss 0 (2021)
institution DOAJ
collection DOAJ
language EN
topic 4ig b7-h3
2ig b7-h3
acute myeloid leukemia
prognosis
Biotechnology
TP248.13-248.65
spellingShingle 4ig b7-h3
2ig b7-h3
acute myeloid leukemia
prognosis
Biotechnology
TP248.13-248.65
Wei Zhang
Lingyi Zhang
Jun Qian
Jiang Lin
Qiaoyun Chen
Qian Yuan
Jingdong Zhou
Tingjuan Zhang
Jinning Shi
Hong Zhou
Expression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia
description B7-H3 isoforms, 4IgB7-H3 (4Ig) and 2IgB7-H3 (2Ig) expression characteristics in acute myeloid leukemia (AML) remain unknown. This study investigated mRNA and membrane protein expression of two isoforms in AML cell lines and de novo patients by using RT-PCR and flow cytometry, and analyzed the B7-H3 promoter methylation state by utilizing RQ-MSP. 4Ig was the dominant B7-H3 isoform. 2Ig mRNA expression rate and abundance were elevated in AML in comparison with controls (P=0.000 and 0.000), while no significant difference in 4Ig (P=0.802, P=0.398). Membrane protein levels of B7-H3 isoforms in AML was higher than controls, detected by total B7-H3 expression rate (P=0.002), total B7-H3 mean fluorescence intensity (MFI) ratio of blast cells and lymphocytes (MFI ratio) (P=0.000), and 4Ig B7-H3 MFI ratio (P=0.005). Compared with 2Iglow group, 2Ighigh patients had older age, lower NPM1 mutation, higher FLT3-ITD mutation, and declining complete remission (CR) rates (P=0.026, 0.012, 0.047, and 0.028). In B7-H3high group, there was a trend towards older age, –M4 and M5, worse karyotype, and lower CR rates, although with no marked difference (P>0.05). The overall survival (OS) of 2Ighigh and B7-H3high groups were shorter than that of 2Iglow and B7-H3low groups in the whole and non-M3 AML cohorts (P=0.006 and 0.046; P=0.003 and 0.032). Besides, an unmethylated B7-H3 promoter was identified. In conclusion, 2Ig mRNA and total B7-H3 isoforms membrane protein tended to have potential diagnostic value for AML. Specifically, high 2Ig mRNA expression and total B7-H3 membrane protein expression indicate worse OS. 4Ig and 2Ig expression are methylation-independent.
format article
author Wei Zhang
Lingyi Zhang
Jun Qian
Jiang Lin
Qiaoyun Chen
Qian Yuan
Jingdong Zhou
Tingjuan Zhang
Jinning Shi
Hong Zhou
author_facet Wei Zhang
Lingyi Zhang
Jun Qian
Jiang Lin
Qiaoyun Chen
Qian Yuan
Jingdong Zhou
Tingjuan Zhang
Jinning Shi
Hong Zhou
author_sort Wei Zhang
title Expression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia
title_short Expression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia
title_full Expression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia
title_fullStr Expression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia
title_full_unstemmed Expression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia
title_sort expression characteristic of 4ig b7-h3 and 2ig b7-h3 in acute myeloid leukemia
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/d8c8d09eae8f4426a9cd63794b646a46
work_keys_str_mv AT weizhang expressioncharacteristicof4igb7h3and2igb7h3inacutemyeloidleukemia
AT lingyizhang expressioncharacteristicof4igb7h3and2igb7h3inacutemyeloidleukemia
AT junqian expressioncharacteristicof4igb7h3and2igb7h3inacutemyeloidleukemia
AT jianglin expressioncharacteristicof4igb7h3and2igb7h3inacutemyeloidleukemia
AT qiaoyunchen expressioncharacteristicof4igb7h3and2igb7h3inacutemyeloidleukemia
AT qianyuan expressioncharacteristicof4igb7h3and2igb7h3inacutemyeloidleukemia
AT jingdongzhou expressioncharacteristicof4igb7h3and2igb7h3inacutemyeloidleukemia
AT tingjuanzhang expressioncharacteristicof4igb7h3and2igb7h3inacutemyeloidleukemia
AT jinningshi expressioncharacteristicof4igb7h3and2igb7h3inacutemyeloidleukemia
AT hongzhou expressioncharacteristicof4igb7h3and2igb7h3inacutemyeloidleukemia
_version_ 1718409502538072064